Inter and intra-tumoral heterogeneity as a platform for personalized therapies in medulloblastoma.

Danilenko, Marina; Clifford, Steven C; Schwalbe, Edward C

Danilenko, Marina; Clifford, Steven C; Schwalbe, Edward C.

Afiliação

Danilenko M; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Clifford SC; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Schwalbe EC; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; Department of Applied Sciences, Northumbria University, Newcastle upon Tyne, UK. Electronic address: ed.schwalbe@northumbria.ac.uk.

Pharmacol Ther ; 228: 107828, 2021 12.

Article em En | MEDLINE | ID: mdl-33662447

Assuntos

Neoplasias Cerebelares; Meduloblastoma; Neoplasias Cerebelares/tratamento farmacológico; Neoplasias Cerebelares/genética; Humanos; Meduloblastoma/tratamento farmacológico; Meduloblastoma/genética; Medicina de Precisão

Palavras-chave

Inter-tumoral heterogeneity; Intra-tumoral heterogeneity; Medulloblastoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cerebelares / Meduloblastoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Pharmacol Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google